نتایج جستجو برای: beta thalasemic major
تعداد نتایج: 791297 فیلتر نتایج به سال:
background: iron chelators are an important part of management of patients with thalassemia. it is prudent to compare efficacy of different iron chelators in treatment of iron overload in these patients who receive regular blood transfusion. we aimed to compare the efficacy and safety of available oral iron chelator; deferasirox (exjade®) with deferasirox (osveral®) in reducing iron overload in...
Background Patients with beta thalassemia suffer from increased susceptibility to infections and putridity plays a major role in the patient's morbidity and mortality. The risk of transfusion-transmitted viral infection is well known in these patients. However, there is dearth of information about the seroprevalence of herpes simplex virus (HSV) infection in patients with beta thalassem...
background patients with beta thalassemia suffer from increased susceptibility to infections and putridity plays a major role in the patient's morbidity and mortality. the risk of transfusion-transmitted viral infection is well known in these patients. however, there is dearth of information about the seroprevalence of herpes simplex virus (hsv) infection in patients with beta thalassemia in li...
introduction: cardiac dysfunctions have been well known in patients with major thalassemia. some studies have focused on differences in blood pressure and heart rate between these patients and normal population, while this view has not been proven in other studies. given the importance of hemodynamic factors in the health of these individuals, we intend to test the hypothesis as to whether or n...
background: β-thalassemia as a hereditary disease is defined as defective synthesis of β-globin chains, resulting in erythropoiesis abnormalities and severe anemia. different studies have shown that cytokines and cytokine gene polymorphisms play a major role in the pathogenesis of β-thalassemia. single nucleotide polymorphisms (snps) within the promoter region or other regulatory sequences ...
Background: Beta-thalassemia major is a very severe blood disease, its Clinical signs are premature and appear from 3 to 6 months of age. It is one of the most common monogenic diseases in the world and in Iran, and if it is not diagnosed and treated during the first years of life, it will lead to death. In this study, to check the factors affecting the survival of patients with beta-thalassemi...
Background & Objective: Beta-thalassemia major, impairs body and central nervous system functions. Decline in Perceptual and cognitive abilities in this disease, especially in children, and eventual reduced quality of life, is one of the possible complications of this disease. The purpose of this study was to evaluate the cognitive perception of two abilities to think abstractly and visual org...
Background: Patients with beta-thalessemia major present with severe anemia and need continous transfusion therapy. An important complication of beta-thalessemia major is iron deposition in cardiac tissue, resulting in fibrosis and dysfunction. Cardiac involvement is the major cause of death in beta-thalessemia major. The purpose of this study was to assess cardiac disease patients with bet...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید